by chuck_ltd | 14 Feb, 2017 | Reimbursement
In mid-November 2016 the government issued directives to review the pricing and reimbursement system and the national financing system for medicinal products. The government declared that the existing system is complex and complicated and must be improved in order to...
by chuck_ltd | 7 Jan, 2016 | CHCUK News & Articles, News, Patient Centricity
Introduction The Stockholm Administrative Court of Appeal recently considered whether financial aspects can be assessed when determining whether there are special requirements for granting a named patient permission. The court dismissed arguments that high prices and...
